Overexpression of MFN2 alleviates sorafenib-induced cardiomyocyte necroptosis via the MAM-CaMKIIδ pathway in vitro and in vivo

Background: The continued success of oncological therapeutics is dependent on the mitigation of treatment-related adverse events, particularly cardiovascular toxicities. As such, there is an important need to understand the basic mechanisms of drug toxicities in the process of antitumor therapy. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ziping, Song, Haixu, Liu, Dan, Yan, Bing, Wang, Daowen, Zhang, Yan, Zhao, Xiaojie, Tian, Xiaoxiang, Yan, Chenghui, Han, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771548/
https://www.ncbi.nlm.nih.gov/pubmed/35154486
http://dx.doi.org/10.7150/thno.65716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771548/
https://www.ncbi.nlm.nih.gov/pubmed/35154486
http://dx.doi.org/10.7150/thno.65716

Ejemplares similares